169 related articles for article (PubMed ID: 30316676)
1. Early Immunologic Response of Irreversible Electroporation versus Cryoablation in a Rodent Model of Pancreatic Cancer.
White SB; Zhang Z; Chen J; Gogineni VR; Larson AC
J Vasc Interv Radiol; 2018 Dec; 29(12):1764-1769. PubMed ID: 30316676
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
[TBL] [Abstract][Full Text] [Related]
3. Controllable Moderate Heating Enhances the Therapeutic Efficacy of Irreversible Electroporation for Pancreatic Cancer.
Edelblute CM; Hornef J; Burcus NI; Norman T; Beebe SJ; Schoenbach K; Heller R; Jiang C; Guo S
Sci Rep; 2017 Sep; 7(1):11767. PubMed ID: 28924200
[TBL] [Abstract][Full Text] [Related]
4. Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model.
Narayanan JSS; Ray P; Hayashi T; Whisenant TC; Vicente D; Carson DA; Miller AM; Schoenberger SP; White RR
Cancer Immunol Res; 2019 Oct; 7(10):1714-1726. PubMed ID: 31409607
[TBL] [Abstract][Full Text] [Related]
5. Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse pancreatic cancer model.
Imran KM; Brock RM; Beitel-White N; Powar M; Orr K; Aycock KN; Alinezhadbalalami N; Salameh ZS; Eversole P; Tintera B; Markov Madanick J; Hendricks-Wenger A; Coutermarsh-Ott S; Davalos RV; Allen IC
Front Immunol; 2024; 15():1352821. PubMed ID: 38711517
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of irreversible electroporation ablation combined with natural killer cells in treating locally advanced pancreatic cancer.
Pan Q; Hu C; Fan Y; Wang Y; Li R; Hu X
J BUON; 2020; 25(3):1643-1649. PubMed ID: 32862617
[TBL] [Abstract][Full Text] [Related]
7. Irreversible Electroporation versus Radiofrequency Ablation: A Comparison of Local and Systemic Effects in a Small-Animal Model.
Bulvik BE; Rozenblum N; Gourevich S; Ahmed M; Andriyanov AV; Galun E; Goldberg SN
Radiology; 2016 Aug; 280(2):413-24. PubMed ID: 27429143
[TBL] [Abstract][Full Text] [Related]
8. Pain Analysis in Patients with Pancreatic Carcinoma: Irreversible Electroporation versus Cryoablation.
Li J; Sheng S; Zhang K; Liu T
Biomed Res Int; 2016; 2016():2543026. PubMed ID: 28074177
[TBL] [Abstract][Full Text] [Related]
9. Short-term clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cancer.
Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
Immunol Lett; 2017 Jun; 186():20-27. PubMed ID: 28392199
[TBL] [Abstract][Full Text] [Related]
10. Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model.
Shankara Narayanan JS; Hayashi T; Erdem S; McArdle S; Tiriac H; Ray P; Pu M; Mikulski Z; Miller A; Messer K; Carson D; Schoenberger S; White RR
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36634919
[TBL] [Abstract][Full Text] [Related]
11. Physical and Chemical Enhancement of and Adaptive Resistance to Irreversible Electroporation of Pancreatic Cancer.
Shao Q; Liu F; Chung C; Elahi-Gedwillo K; Provenzano PP; Forsyth B; Bischof JC
Ann Biomed Eng; 2018 Jan; 46(1):25-36. PubMed ID: 28983745
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of irreversible electroporation in the treatment of advanced pancreatic cancer.
Moir J; White SA; French JJ; Littler P; Manas DM
Eur J Surg Oncol; 2014 Dec; 40(12):1598-604. PubMed ID: 25307210
[TBL] [Abstract][Full Text] [Related]
13. Comparison between cryoablation and irreversible electroporation of rabbit livers at a location close to the gallbladder.
Zeng J; Qin Z; Zhou L; Fang G; Chen J; Li J; Niu L; Liang B; Xu K
Radiol Oncol; 2017 Mar; 51(1):40-46. PubMed ID: 28265231
[TBL] [Abstract][Full Text] [Related]
14. Irreversible electroporation ablation overcomes tumor-associated immunosuppression to improve the efficacy of DC vaccination in a mice model of pancreatic cancer.
Yang J; Eresen A; Shangguan J; Ma Q; Yaghmai V; Zhang Z
Oncoimmunology; 2021 Feb; 10(1):1875638. PubMed ID: 33643692
[TBL] [Abstract][Full Text] [Related]
15. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival.
Martin RC; McFarland K; Ellis S; Velanovich V
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S443-9. PubMed ID: 23128941
[TBL] [Abstract][Full Text] [Related]
16. Ablation Strategies for Locally Advanced Pancreatic Cancer.
Linecker M; Pfammatter T; Kambakamba P; DeOliveira ML
Dig Surg; 2016; 33(4):351-9. PubMed ID: 27216160
[TBL] [Abstract][Full Text] [Related]
17. Histological analysis of human pancreatic carcinoma following irreversible electroporation in a nude mouse model.
Su JJ; Xu K; Wang PF; Zhang HY; Chen YL
World J Gastrointest Oncol; 2018 Dec; 10(12):476-486. PubMed ID: 30595801
[TBL] [Abstract][Full Text] [Related]
18. The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer: a systematic review of safety and efficacy.
Ansari D; Kristoffersson S; Andersson R; Bergenfeldt M
Scand J Gastroenterol; 2017 Nov; 52(11):1165-1171. PubMed ID: 28687047
[TBL] [Abstract][Full Text] [Related]
19. Irreversible electroporation ablation: creation of large-volume ablation zones in in vivo porcine liver with four-electrode arrays.
Appelbaum L; Ben-David E; Faroja M; Nissenbaum Y; Sosna J; Goldberg SN
Radiology; 2014 Feb; 270(2):416-24. PubMed ID: 24126371
[TBL] [Abstract][Full Text] [Related]
20. Immunologic response to cryoablation of breast cancer.
Sabel MS; Nehs MA; Su G; Lowler KP; Ferrara JL; Chang AE
Breast Cancer Res Treat; 2005 Mar; 90(1):97-104. PubMed ID: 15770533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
